Remove 2002 Remove Fraud Remove Governance Remove Medicare
article thumbnail

What is HIPAA?

HIPAA Journal

Title II: Preventing health care fraud and abuse; administration simplification; medical liability reform. Title III: Tax-related health provisions governing medical savings accounts. Title V: Revenue offsets governing tax deductions for employers. Title IV: Application and enforcement of group health plan requirements.

HIPAA 88
article thumbnail

Beneficiary inducements…don’t cross that line

YouCompli

But tactics common in other industries might be considered illegal beneficiary inducements in healthcare, especially for beneficiaries of federal programs like Medicare or Medicaid. Co-pay waivers,” “insurance only billing,” “Medicare accepted as payment in full,” and “free gift for new patients” are just some examples.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

OIG Approves Cash Equivalents Paid to Patients Participating in Contingency Management Program Offered Through Digital Health Technology

Health Care Law Brief

As early as 2002 and as highlighted in recent guidance , OIG has explained its longstanding concerns relating to the offering of incentives intended to induce beneficiaries to obtain federally reimbursable items and services when those incentives have been cash or cash equivalents. The OIG highlighted four specific reasons. Key Takeaways.

Fraud 52
article thumbnail

What Are THE 3 Major Things Addressed in the HIPAA Law?

HIPAA Journal

Had the level of abuse and fraud in the healthcare industry been allowed to continue, tens of billions of dollars would have been lost to unscrupulous actors. However, when HIPAA was passed, the standards governing health care data, patients´ rights, and the flow of information were still several years away. In March 1996, Rep.

HIPAA 119
article thumbnail

Logical Contradiction Doctrine:  Buckman for Textualists

Drug & Device Law

470 (1996), was decided – removing express preemption as a defense for manufacturers of §510(k) products So defendants moved on fraud on the FDA under an implied preemption theory and won. Mensing , 564 U.S. Mensing , 564 U.S. Lohr , 518 U.S. Davidowitz , 312 U.S. Davidowitz , 312 U.S.

FDA 72